Gilead Sciences and Container Store skid; Nordstrom climbs

The biotechnology company forecast disappointing sales as revenue from its hepatitis C drugs weakens.

The diagnostic test company said sales of hereditary cancer tests started growing again in the latest quarter.

The bakery chain announced solid fourth-quarter results and gave a better-than-expected forecast for sales at older locations.